Funder
Janssen Research and Development
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
2. Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst. 2017;109(9):djx030. https://doi.org/10.1093/jnci/djx030.
3. Davies A, Conteduca V, Zoubeidi A, Beltran H. Biological evolution of castration-resistant prostate cancer. Eur Urol Focus. 2019;5(2):147–54. https://doi.org/10.1016/j.euf.2019.01.016.
4. American Cancer Society. Prostate cancer early detection, diagnosis, and staging: finding prostate cancer early. https://www.cancer.org/content/dam/CRC/PDF/Public/8795.00.pdf. Accessed 3 Jul 2023.
5. Wallace KL, Landsteiner A, Bunner SH, Engel-Nitz NM, Luckenbaugh AN. Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in the United States. Cancer Causes Control. 2021;32(12):1365–74. https://doi.org/10.1007/s10552-021-01484-4.